FILL
FILL
FILL
FILL (if available)
Initial variant characteristics (transmissibility of variants at t=0, and how uncertainty or non-identifiability was handled)
FILL
Details about calibration of immunity at t=0 (calibration period considered, assumptions about/fitting of past immune escape and waning immunity, is the same calibration process used for all scenarios?)
FILL
Details about modeling of immune escape after t=0 (including how projected immune escape is handled in scenarios, e.g., whether a stepwise or continuous escape was considered)
FILL
Assumptions regarding waning immunity against infection and symptoms (including values used for the duration and level of protection against infection or symptomatic disease, whether a point estimate was used or a range, and distribution used)
FILL
Assumptions regarding waning immunity against severe disease (including whether immunity against severe disease, conditional on infection, is fixed vs declines over time; and if it wanes, specify how)
FILL
Describe the process used to set or calibrate disease severity, ie P(hosp given current infection) and P(death given current infection) details. What are the datasets used for calibration of the death targets?
FILL
FILL
FILL
FILL